Herpesviruses: Interfering innate immunity by targeting viral sensing and interferon pathways

Reviews in Medical Virology

Volumn 25, Issue 3, 2015, Pages 187-201

  Kumari, Puja ^a   Narayanan, Sathish ^a   Kumar, Himanshu ^a,b  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH BHOPAL   (India)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW STROMAL CELL ANTIGEN 2; DNA; INTERFERON; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; JANUS KINASE; MYELOID DIFFERENTIATION FACTOR 88; NUCLEAR DOMAIN 10; PATTERN RECOGNITION RECEPTOR; PHOSPHOTRANSFERASE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; RIBONUCLEASE L; STAT PROTEIN; TANK BINDING KINASE 1; TETHERIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; VIPERIN; IMMUNOGLOBULIN RECEPTOR; INTERFERON REGULATORY FACTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ANTIVIRAL ACTIVITY; CYTOSOL; GENETIC TRANSCRIPTION; HERPES VIRUS INFECTION; HERPESVIRIDAE; HOST CELL; HUMAN; IMMUNE EVASION; IMMUNOCOMPETENCE; INNATE IMMUNITY; LIFE CYCLE; MOLECULAR SENSOR; NONHUMAN; POSITIVE FEEDBACK; REVIEW; SIGNAL TRANSDUCTION; VIRION; VIRUS GENE; VIRUS GENOME; VIRUS INTERFERENCE; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; ANIMAL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; INTERFERONS; JANUS KINASES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 84928766477     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1836     Document Type: Review

References (125)

1. Cullen BR. MicroRNAs as mediators of viral evasion of the immune system. Nature Immunology 2013; 14: 205-210. DOI:10.1038/ni.2537.
2. Boehmer PE, Nimonkar AV. Herpes virus replication. IUBMB Life 2003; 55: 13-22. DOI:10.1080/1521654031000070645.
3. Edelman DC. Human herpesvirus 8 - a novel human pathogen. Virology Journal 2005; 2: 78. DOI:10.1186/1743-422X-2-78.
4. Gilden DH, Mahalingam R, Cohrs RJ, Tyler KL. Herpesvirus infections of the nervous system. Nature Clinical Practice Neurology 2007; 3: 82-94. DOI:10.1038/ncpneuro0401.
5. Boehme KW, Singh J, Perry ST, Compton T. Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. Journal of Virology 2004; 78: 1202-1211.
6. Juckem LK, Boehme KW, Feire AL, Compton T. Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. Journal of Immunology 2008; 180: 4965-4977.
7. Mossman KL, Macgregor PF, Rozmus JJ, Goryachev AB, Edwards AM, Smiley JR. Herpes simplex virus triggers and then disarms a host antiviral response. Journal of Virology 2001; 75: 750-758. DOI:10.1128/JVI.75.2.750-758.2001.
8. Unterholzner L, Bowie AG. The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. Biochemical Pharmacology 2008; 75: 589-602. DOI:10.1016/j.bcp.2007.07.043.
9. Takaoka A, Wang Z, Choi MK, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448: 501-505. DOI:10.1038/nature06013.
10. Rasmussen SB, Jensen SB, Nielsen C, et al. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene-like receptors, which synergize to induce type I interferon production. Journal of General Virology 2009; 90: 74-78. DOI:10.1099/vir.0.005389-0.
11. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. RIG-I- dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nature Immunology 2009; 10: 1065-1072. DOI:10.1038/ni.1779.
12. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009; 138: 576-591. DOI:10.1016/j.cell.2009.06.015.
13. Boyle KA, Pietropaolo RL, Compton T. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Molecular and Cellular Biology 1999; 19: 3607-3613.
14. Nicholl MJ, Robinson LH, Preston CM. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. Journal of General Virology 2000; 81: 2215-2218.
15. Preston CM, Harman AN, Nicholl MJ. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. Journal of Virology 2001; 75: 8909-8916. DOI:10.1128/JVI.75.19.8909-8916.2001.
16. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317: 1522-1527. DOI:10.1126/science.1139522.
17. Sathish N, Yuan Y. Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview. Journal of Virology 2011; 85: 10934-10944. DOI:10.1128/JVI.00687-11.
18. Xing J, Wang S, Lin R, Mossman KL, Zheng C. Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5. Journal of Virology 2012; 86: 3528-3540. DOI:10.1128/JVI.06713-11.
19. Burdette DL, Vance RE. STING and the innate immune response to nucleic acids in the cytosol. Nature Immunology 2013; 14: 19-26. DOI:10.1038/ni.2491.
20. Kawai T, Sato S, Ishii KJ, et al. Interferon-alpha induction through toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunology 2004; 5: 1061-1068. DOI:10.1038/ni1118.
21. Justesen J, Hartmann R, Kjeldgaard NO. Gene structure and function of the 2′-5′-oligoadenylate synthetase family. Cellular and Molecular Life Sciences 2000; 57: 1593-1612.
22. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annual Review of Biochemistry 1998; 67: 227-264. DOI:10.1146/annurev.biochem.67.1.227.
23. Chin KC, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proceedings of the National Academy of Sciences of the United States of America 2001; 98: 15125-15130. DOI:10.1073/pnas.011593298.
24. Neil SJ. The antiviral activities of tetherin. Current Topics in Microbiology and Immunology 2013; 371: 67-104. DOI:10.1007/978-3-642-37765-5_3.
25. Peri P, Mattila RK, Kantola H, et al. Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells. Virology Journal 2008; 5: 140. DOI:10.1186/1743-422X-5-140.
26. Pasieka TJ, Baas T, Carter VS, Proll SC, Katze MG, Leib DA. Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response. Journal of Virology 2006; 80: 7600-7612. DOI:10.1128/JVI.00333-06.
27. Chang WL, Barry PA, Szubin R, Wang D, Baumgarth N. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 2009; 390: 330-337. DOI:10.1016/j.virol.2009.05.013.
28. Lagos D, Vart RJ, Gratrix F, et al. Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. Cell Host & Microbe 2008; 4: 470-483. DOI:10.1016/j.chom.2008.09.012.
29. Kok KH, Lui PY, Ng MH, Siu KL, Au SW, Jin DY. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host & Microbe 2011; 9: 299-309. DOI:10.1016/j.chom.2011.03.007.
30. Kew C, Lui PY, Chan CP, et al. Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein. Journal of Virology 2013; 87: 13141-13149. DOI:10.1128/JVI.02564-13.
31. Oshiumi H, Matsumoto M, Hatakeyama S, Seya T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. Journal of Biological Chemistry 2009; 284: 807-817. DOI:10.1074/jbc.M804259200.
32. Scott I. Degradation of RIG-I following cytomegalovirus infection is independent of apoptosis. Microbes and Infection 2009; 11: 973-979. DOI:10.1016/j.micinf.2009.07.001.
33. Inn KS, Lee SH, Rathbun JY, et al. Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. Journal of Virology 2011; 85: 10899-10904. DOI:10.1128/JVI.00690-11.
34. Pham TH, Kwon KM, Kim YE, Kim KK, Ahn JH. DNA sensing-independent inhibition of herpes simplex virus 1 replication by DAI/ZBP1. Journal of Virology 2013; 87: 3076-3086. DOI:10.1128/JVI.02860-12.
35. Keating SE, Baran M, Bowie AG. Cytosolic DNA sensors regulating type I interferon induction. Trends in Immunology 2011; 32: 574-581. DOI:10.1016/j.it.2011.08.004.
36. Orzalli MH, DeLuca NA, Knipe DM. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proceedings of the National Academy of Sciences of the United States of America 2012; 109: E3008-E3017. DOI:10.1073/pnas.1211302109.
37. Boutell C, Sadis S, Everett RD. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. Journal of Virology 2002; 76: 841-850.
38. Everett RD, Orr A, Preston CM. A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO Journal 1998; 17: 7161-7169. DOI:10.1093/emboj/17.24.7161.
39. Gariano GR, Dell'Oste V, Bronzini M, et al. The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathogen 2012; 8: e1002498. DOI:10.1371/journal.ppat.1002498.
40. Cristea IM, Moorman NJ, Terhune SS, et al. Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. Journal of Virology 2010; 84: 7803-7814. DOI:10.1128/JVI.00139-10.
41. van Lint AL, Murawski MR, Goodbody RE, et al. Herpes simplex virus immediate-early ICP0 protein inhibits toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. Journal of Virology 2010; 84: 10802-10811. DOI:10.1128/JVI.00063-10.
42. Smith PD, Shimamura M, Musgrove LC, et al. Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responses. Journal of Immunology 2014; 193: 5604-5612. DOI:10.4049/jimmunol.1302608.
43. Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, Ziegelbauer JM. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. Journal of Virology 2012; 86: 11663-11674. DOI:10.1128/JVI.01147-12.
44. Zhao Q, Liang D, Sun R, et al. Kaposi's sarcoma-associated herpesvirus-encoded RTA impairs innate immunity via ubiquitin-mediated degradation of MyD88. Journal of Virology 2014. DOI:10.1128/JVI.02591-14.
45. Ahmad H, Gubbels R, Ehlers E, et al. Kaposi sarcoma-associated herpesvirus degrades cellular toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF). Journal of Biological Chemistry 2011; 286: 7865-7872. DOI:10.1074/jbc.M110.191452.
46. West JA, Wicks M, Gregory SM, et al. An important role for mitochondrial antiviral signaling protein in the Kaposi's sarcoma-associated herpesvirus life cycle. Journal of Virology 2014; 88: 5778-5787. DOI:10.1128/JVI.03226-13.
47. Daubeuf S, Singh D, Tan Y, et al. HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood 2009; 113: 3264-3275. DOI:10.1182/blood-2008-07-168203.
48. Sen J, Liu X, Roller R, Knipe DM. Herpes simplex virus US3 tegument protein inhibits toll-like receptor 2 signaling at or before TRAF6 ubiquitination. Virology 2013; 439: 65-73. DOI:10.1016/j.virol.2013.01.026.
49. Wang S, Wang K, Li J, Zheng C. Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3. Journal of Virology 2013; 87: 11851-11860. DOI:10.1128/JVI.01211-13.
50. Ikeda F, Hecker CM, Rozenknop A, et al. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO Journal 2007; 26: 3451-3462. DOI:10.1038/sj.emboj.7601773.
51. Ma Y, Jin H, Valyi-Nagy T, Cao Y, Yan Z, He B. Inhibition of TANK binding kinase 1 by herpes simplex virus 1 facilitates productive infection. Journal of Virology 2012; 86: 2188-2196. DOI:10.1128/JVI.05376-11.
52. Verpooten D, Ma Y, Hou S, Yan Z, He B. Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. Journal of Biological Chemistry 2009; 284: 1097-1105. DOI:10.1074/jbc.M805905200.
53. Liang Q, Fu B, Wu F, Li X, Yuan Y, Zhu F. ORF45 of Kaposi's sarcoma-associated herpesvirus inhibits phosphorylation of interferon regulatory factor 7 by IKKepsilon and TBK1 as an alternative substrate. Journal of Virology 2012; 86: 10162-10172. DOI:10.1128/JVI.05224-11.
54. Liang D, Gao Y, Lin X, et al. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKepsilon. Cell Research 2011; 21: 793-806. DOI:10.1038/cr.2011.5.
55. Lin R, Noyce RS, Collins SE, Everett RD, Mossman KL. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. Journal of Virology 2004; 78: 1675-1684.
56. Paladino P, Collins SE, Mossman KL. Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS One 2010; 5: e10428. DOI:10.1371/journal.pone.0010428.
57. Melroe GT, DeLuca NA, Knipe DM. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. Journal of Virology 2004; 78: 8411-8420. DOI:10.1128/JVI.78.16.8411-8420.2004.
58. Cassady KA, Saunders U, Shimamura M. Deltagamma(1)134.5 herpes simplex viruses encoding human cytomegalovirus IRS1 or TRS1 induce interferon regulatory factor 3 phosphorylation and an interferon-stimulated gene response. Journal of Virology 2012; 86: 610-614. DOI:10.1128/JVI.05099-11.
59. Xing J, Ni L, Wang S, Wang K, Lin R, Zheng C. Herpes simplex virus 1-encoded tegument protein VP16 abrogates the production of beta interferon (IFN) by inhibiting NF-kappaB activation and blocking IFN regulatory factor 3 to recruit its coactivator CBP. Journal of Virology 2013; 87: 9788-9801. DOI:10.1128/JVI.01440-13.
60. Melroe GT, Silva L, Schaffer PA, Knipe DM. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: potential role in blocking IFN-beta induction. Virology 2007; 360: 305-321. DOI:10.1016/j.virol.2006.10.028.
61. Abate DA, Watanabe S, Mocarski ES. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. Journal of Virology 2004; 78: 10995-11006. DOI:10.1128/JVI.78.20.10995-11006.2004.
62. Lee HR, Kim MH, Lee JS, Liang C, Jung JU. Viral interferon regulatory factors. Journal of Interferon and Cytokine Research 2009; 29: 621-627. DOI:10.1089/jir.2009.0067.
63. Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annual Review of Microbiology 2003; 57: 609-639. DOI:10.1146/annurev.micro.57.030502.090824.
64. Lin R, Genin P, Mamane Y, et al. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 2001; 20: 800-811. DOI:10.1038/sj.onc.1204163.
65. Joo CH, Shin YC, Gack M, Wu L, Levy D, Jung JU. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. Journal of Virology 2007; 81: 8282-8292. DOI:10.1128/JVI.00235-07.
66. Fuld S, Cunningham C, Klucher K, Davison AJ, Blackbourn DJ. Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. Journal of Virology 2006; 80: 3092-3097. DOI:10.1128/JVI.80.6.3092-3097.2006.
67. Wies E, Hahn AS, Schmidt K, et al. The Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5. Journal of Biological Chemistry 2009; 284: 8525-8538. DOI:10.1074/jbc.M809252200.
68. Bi X, Yang L, Mancl ME, Barnes BJ. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction. Journal of Interferon and Cytokine Research 2011; 31: 373-382. DOI:10.1089/jir.2010.0084.
69. Burysek L, Yeow WS, Lubyova B, et al. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. Journal of Virology 1999; 73: 7334-7342.
70. Lefort S, Soucy-Faulkner A, Grandvaux N, Flamand L. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression. Journal of Virology 2007; 81: 10950-10960. DOI:10.1128/JVI.00183-07.
71. Cloutier N, Flamand L. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter. Journal of Biological Chemistry 2010; 285: 7208-7221. DOI:10.1074/jbc.M109.018838.
72. Hwang S, Kim KS, Flano E, et al. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host & Microbe 2009; 5: 166-178. DOI:10.1016/j.chom.2008.12.013.
73. Areste C, Mutocheluh M, Blackbourn DJ. Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. Journal of Biological Chemistry 2009; 284: 23272-23285. DOI:10.1074/jbc.M109.033290.
74. Zhu FX, King SM, Smith EJ, Levy DE, Yuan Y. A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 5573-5578. DOI:10.1073/pnas.082420599.
75. Yu Y, Wang SE, Hayward GS. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 2005; 22: 59-70. DOI:10.1016/j.immuni.2004.11.011.
76. Chee AV, Roizman B. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. Journal of Virology 2004; 78: 4185-4196.
77. Ragimbeau J, Dondi E, Alcover A, Eid P, Uze G, Pellegrini S. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO Journal 2003; 22: 537-547. DOI:10.1093/emboj/cdg038.
78. Miller DM, Zhang Y, Rahill BM, Waldman WJ, Sedmak DD. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. Journal of Immunology 1999; 162: 6107-6113.
79. Bisson SA, Page AL, Ganem D. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction. Journal of Virology 2009; 83: 5056-5066. DOI:10.1128/JVI.02516-08.
80. Zhu FX, Sathish N, Yuan Y. Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45. PLoS One 2010; 5: e10573. DOI:10.1371/journal.pone.0010573.
81. Johnson KE, Song B, Knipe DM. Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling. Virology 2008; 374: 487-494. DOI:10.1016/j.virol.2008.01.001.
82. Yokota S, Yokosawa N, Okabayashi T, et al. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. Journal of Virology 2004; 78: 6282-6286. DOI:10.1128/JVI.78.12.6282-6286.2004.
83. Johnson KE, Knipe DM. Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation. Virology 2010; 396: 21-29. DOI:10.1016/j.virol.2009.09.021.
84. Yokota S, Yokosawa N, Kubota T, et al. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and Janus kinases during an early infection stage. Virology 2001; 286: 119-124. DOI:10.1006/viro.2001.0941.
85. Le VT, Trilling M, Wilborn M, Hengel H, Zimmermann A. Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. Journal of General Virology 2008; 89: 2416-2426. DOI:10.1099/vir.0.2008/001669-0.
86. Huh YH, Kim YE, Kim ET, et al. Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. Journal of Virology 2008; 82: 10444-10454. DOI:10.1128/JVI.00833-08.
87. Paulus C, Krauss S, Nevels M. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proceedings of the National Academy of Sciences of the United States of America 2006; 103: 3840-3845. DOI:10.1073/pnas.0600007103.
88. Li Y, Zhang C, Chen X, et al. ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1. Journal of Biological Chemistry 2011; 286: 24785-24792. DOI:10.1074/jbc.M111.232439.
89. He B, Gross M, Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double- stranded RNA-activated protein kinase. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 843-848.
90. Cassady KA, Gross M. The herpes simplex virus type 1 U(S)11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain. Journal of Virology 2002; 76: 2029-2035.
91. Cassady KA, Gross M, Roizman B. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. Journal of Virology 1998; 72: 8620-8626.
92. Cassady KA, Gross M, Roizman B. The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha. Journal of Virology 1998; 72: 7005-7011.
93. Hakki M, Marshall EE, De Niro KL, Geballe AP. Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. Journal of Virology 2006; 80: 11817-11826. DOI:10.1128/JVI.00957-06.
94. Burysek L, Pitha PM. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. Journal of Virology 2001; 75: 2345-2352. DOI:10.1128/JVI.75.5.2345-2352.2001.
95. Esteban M, Garcia MA, Domingo-Gil E, Arroyo J, Nombela C, Rivas C. The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation. Journal of General Virology 2003; 84: 1463-1470.
96. Sanchez R, Mohr I. Inhibition of cellular 2′-5′ oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein. Journal of Virology 2007; 81: 3455-3464. DOI:10.1128/JVI.02520-06.
97. Poppers J, Mulvey M, Khoo D, Mohr I. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. Journal of Virology 2000; 74: 11215-11221.
98. Child SJ, Hakki M, De Niro KL, Geballe AP. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. Journal of Virology 2004; 78: 197-205.
99. Tan JC, Avdic S, Cao JZ, et al. Inhibition of 2′, 5′-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product. Journal of Virology 2011; 85: 5696-5700. DOI:10.1128/JVI.02463-10.
100. Rossetto CC, Pari GS. Kaposi's sarcoma-associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus- and host cell-encoded proteins and suppresses expression of genes involved in immune modulation. Journal of Virology 2011; 85: 13290-13297. DOI:10.1128/JVI.05886-11.
101. Rivera-Molina YA, Martinez FP, Tang Q. Nuclear domain 10 of the viral aspect. World Journal of Virology 2013; 2: 110-122. DOI:10.5501/wjv.v2.i3.110.
102. Tavalai N, Stamminger T. New insights into the role of the subnuclear structure ND10 for viral infection. Biochimica et Biophysica Acta 2008; 1783: 2207-2221. DOI:10.1016/j.bbamcr.2008.08.004.
103. Zhong S, Muller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP. Role of SUMO-1- modified PML in nuclear body formation. Blood 2000; 95: 2748-2752.
104. Ishov AM, Sotnikov AG, Negorev D, et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. Journal of Cell Biology 1999; 147: 221-234.
105. Knipscheer P, Flotho A, Klug H, et al. Ubc9 sumoylation regulates SUMO target discrimination. Molecular Cell 2008; 31: 371-382. DOI:10.1016/j.molcel.2008.05.022.
106. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP. The mechanisms of PML-nuclear body formation. Molecular Cell 2006; 24: 331-339. DOI:10.1016/j.molcel.2006.09.013.
107. Muller S, Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. Journal of Virology 1999; 73: 5137-5143.
108. Editorial board. Antimicrobial Agents and Chemotherapy 2014; 58: A3. DOI:10.1128/AAC.masthead.58-12.
109. Hagglund R, Van Sant C, Lopez P, Roizman B. Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 631-636. DOI:10.1073/pnas.022531599.
110. Boutell C, Orr A, Everett RD. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. Journal of Virology 2003; 77: 8686-8694.
111. Gu H, Roizman B. The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proceedings of the National Academy of Sciences of the United States of America 2003; 100: 8963-8968. DOI:10.1073/pnas.1533420100.
112. Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, Orr A. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. Journal of Virology 2006; 80: 7995-8005. DOI:10.1128/JVI.00734-06.
113. Lee HR, Kim DJ, Lee JM, et al. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. Journal of Virology 2004; 78: 6527-6542. DOI:10.1128/JVI.78.12.6527-6542.2004.
114. Korioth F, Maul GG, Plachter B, Stamminger T, Frey J. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Experimental Cell Research 1996; 229: 155-158. DOI:10.1006/excr.1996.0353.
115. Ahn JH, Hayward GS. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. Journal of Virology 1997; 71: 4599-4613.
116. Kang H, Kim ET, Lee HR, et al. Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein. Journal of General Virology 2006; 87: 2181-2190. DOI:10.1099/vir.0.81787-0.
117. Kim YE, Lee JH, Kim ET, et al. Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. Journal of Virology 2011; 85: 11928-11937. DOI:10.1128/JVI.00758-11.
118. Marcos-Villar L, Lopitz-Otsoa F, Gallego P, et al. Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. Journal of Virology 2009; 83: 8849-8858. DOI:10.1128/JVI.00339-09.
119. Marcos-Villar L, Campagna M, Lopitz-Otsoa F, et al. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2. Journal of General Virology 2011; 92: 188-194. DOI:10.1099/vir.0.024984-0.
120. Helbig KJ, Beard MR. The role of viperin in the innate antiviral response. J Mol Biol 2014; 426: 1210-1219. DOI:10.1016/j.jmb.2013.10.019.
121. Shen G, Wang K, Wang S, Cai M, Li ML, Zheng C. Herpes simplex virus 1 counteracts viperin via its virion host shutoff protein UL41. Journal of Virology 2014; 88: 12163-12166. DOI:10.1128/JVI.01380-14.
122. Seo JY, Yaneva R, Hinson ER, Cresswell P. Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 2011; 332: 1093-1097. DOI:10.1126/science.1202007.
123. Zenner HL, Mauricio R, Banting G, Crump CM. Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity. Journal of Virology 2013; 87: 13115-13123. DOI:10.1128/JVI.02167-13.
124. Mansouri M, Viswanathan K, Douglas JL, et al. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. Journal of Virology 2009; 83: 9672-9681. DOI:10.1128/JVI.00597-09.
125. Viswanathan K, Smith MS, Malouli D, Mansouri M, Nelson JA, Fruh K. BST2/Tetherin enhances entry of human cytomegalovirus. PLoS Pathogen 2011; 7: e1002332. DOI:10.1371/journal.ppat.1002332.